Free Trial
NASDAQ:CMND

Clearmind Medicine (CMND) Stock Price, News & Analysis

Clearmind Medicine logo
$1.06 +0.04 (+3.43%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$1.06 0.00 (0.00%)
As of 08/29/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Clearmind Medicine Stock (NASDAQ:CMND)

Key Stats

Today's Range
$1.02
$1.08
50-Day Range
$0.87
$1.16
52-Week Range
$0.80
$2.18
Volume
42,744 shs
Average Volume
60,653 shs
Market Capitalization
$4.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Clearmind Medicine Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

CMND MarketRank™: 

Clearmind Medicine scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Clearmind Medicine.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Clearmind Medicine is -0.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Clearmind Medicine is -0.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Clearmind Medicine has a P/B Ratio of 1.45. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Clearmind Medicine's valuation and earnings.
  • Percentage of Shares Shorted

    9.31% of the float of Clearmind Medicine has been sold short.
  • Short Interest Ratio / Days to Cover

    Clearmind Medicine has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Clearmind Medicine has recently decreased by 48.14%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Clearmind Medicine does not currently pay a dividend.

  • Dividend Growth

    Clearmind Medicine does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.31% of the float of Clearmind Medicine has been sold short.
  • Short Interest Ratio / Days to Cover

    Clearmind Medicine has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Clearmind Medicine has recently decreased by 48.14%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Clearmind Medicine has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.11 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Clearmind Medicine this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Clearmind Medicine to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Clearmind Medicine insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    96.05% of the stock of Clearmind Medicine is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Clearmind Medicine's insider trading history.
Receive CMND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clearmind Medicine and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CMND Stock News Headlines

Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.tc pixel
See More Headlines

CMND Stock Analysis - Frequently Asked Questions

Clearmind Medicine's stock was trading at $1.38 on January 1st, 2025. Since then, CMND stock has decreased by 23.6% and is now trading at $1.0550.

Clearmind Medicine Inc. (NASDAQ:CMND) released its earnings results on Thursday, June, 12th. The company reported ($0.16) earnings per share (EPS) for the quarter.

Shares of Clearmind Medicine reverse split on the morning of Tuesday, November 28th 2023.The 1-30 reverse split was announced on Tuesday, November 28th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Clearmind Medicine (CMND) raised $9 million in an initial public offering on Tuesday, November 15th 2022. The company issued 1,300,000 shares at a price of $6.00-$8.00 per share. Aegis Capital Corp. served as the underwriter for the IPO.

Clearmind Medicine's top institutional investors include AdvisorShares Investments LLC (4.82%).

Shares of CMND stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Clearmind Medicine investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), Meta Platforms (META), AppLovin (APP) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
6/12/2025
Today
9/01/2025
Next Earnings (Estimated)
9/15/2025
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CMND
CIK
1892500
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.26 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-164.79%
Return on Assets
-71.12%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.74
Quick Ratio
1.74

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.73 per share
Price / Book
1.45

Miscellaneous

Outstanding Shares
4,270,000
Free Float
N/A
Market Cap
$4.50 million
Optionable
Not Optionable
Beta
0.97
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:CMND) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners